636 related articles for article (PubMed ID: 20371119)
1. 1alpha,25-Dihydroxyvitamin D3 inhibits transcriptional potential of nuclear factor kappa B in breast cancer cells.
Tse AK; Zhu GY; Wan CK; Shen XL; Yu ZL; Fong WF
Mol Immunol; 2010 May; 47(9):1728-38. PubMed ID: 20371119
[TBL] [Abstract][Full Text] [Related]
2. Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription.
Lu X; Farmer P; Rubin J; Nanes MS
J Cell Biochem; 2004 Jul; 92(4):833-48. PubMed ID: 15211579
[TBL] [Abstract][Full Text] [Related]
3. 1,25-dihydroxyvitamin D3 induces biphasic NF-kappaB responses during HL-60 leukemia cells differentiation through protein induction and PI3K/Akt-dependent phosphorylation/degradation of IkappaB.
Tse AK; Wan CK; Shen XL; Zhu GY; Cheung HY; Yang M; Fong WF
Exp Cell Res; 2007 May; 313(8):1722-34. PubMed ID: 17397830
[TBL] [Abstract][Full Text] [Related]
4. Exchange of a nuclear corepressor between NF-kappaB and CREB mediates inhibition of phosphoenolpyruvate carboxykinase transcription by NF-kappaB.
Yan JH; Gao ZG; Ye JP; Weng JP
Chin Med J (Engl); 2010 Jan; 123(2):221-6. PubMed ID: 20137375
[TBL] [Abstract][Full Text] [Related]
5. 1alpha,25-dihydroxyvitamin D3 and a variety of its natural metabolites transcriptionally repress nuclear-factor-kappaB-mediated interleukin-8 gene expression.
Harant H; Andrew PJ; Reddy GS; Foglar E; Lindley IJ
Eur J Biochem; 1997 Nov; 250(1):63-71. PubMed ID: 9431991
[TBL] [Abstract][Full Text] [Related]
6. 1,25-dihydroxyvitamin D3 impairs NF-κB activation in human naïve B cells.
Geldmeyer-Hilt K; Heine G; Hartmann B; Baumgrass R; Radbruch A; Worm M
Biochem Biophys Res Commun; 2011 Apr; 407(4):699-702. PubMed ID: 21420936
[TBL] [Abstract][Full Text] [Related]
7. Nuclear corepressor is required for inhibition of phosphoenolpyruvate carboxykinase expression by tumor necrosis factor-alpha.
Yan J; Gao Z; Yu G; He Q; Weng J; Ye J
Mol Endocrinol; 2007 Jul; 21(7):1630-41. PubMed ID: 17456789
[TBL] [Abstract][Full Text] [Related]
8. Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor.
Sun J; Kong J; Duan Y; Szeto FL; Liao A; Madara JL; Li YC
Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E315-22. PubMed ID: 16507601
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of NF-kappaB on 1,25-dihydroxyvitamin D(3) and retinoid X receptor function.
Farmer PK; He X; Schmitz ML; Rubin J; Nanes MS
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E213-20. PubMed ID: 10893342
[TBL] [Abstract][Full Text] [Related]
10. Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling.
Schwab M; Reynders V; Loitsch S; Steinhilber D; Stein J; Schröder O
Mol Immunol; 2007 Jul; 44(15):3625-32. PubMed ID: 17521736
[TBL] [Abstract][Full Text] [Related]
11. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
12. IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300.
Hoberg JE; Popko AE; Ramsey CS; Mayo MW
Mol Cell Biol; 2006 Jan; 26(2):457-71. PubMed ID: 16382138
[TBL] [Abstract][Full Text] [Related]
13. The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression.
Ashburner BP; Westerheide SD; Baldwin AS
Mol Cell Biol; 2001 Oct; 21(20):7065-77. PubMed ID: 11564889
[TBL] [Abstract][Full Text] [Related]
14. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
Tse AK; Wan CK; Zhu GY; Shen XL; Cheung HY; Yang M; Fong WF
Mol Immunol; 2007 Apr; 44(10):2647-58. PubMed ID: 17240450
[TBL] [Abstract][Full Text] [Related]
15. Honokiol inhibits TNF-alpha-stimulated NF-kappaB activation and NF-kappaB-regulated gene expression through suppression of IKK activation.
Tse AK; Wan CK; Shen XL; Yang M; Fong WF
Biochem Pharmacol; 2005 Nov; 70(10):1443-57. PubMed ID: 16181613
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness.
Bao BY; Ting HJ; Hsu JW; Yasmin-Karim S; Messing E; Lee YF
J Steroid Biochem Mol Biol; 2010 May; 120(1):11-21. PubMed ID: 20206692
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
Seuter S; Pehkonen P; Heikkinen S; Carlberg C
Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation.
El Gazzar MA; El Mezayen R; Nicolls MR; Dreskin SC
Biochim Biophys Acta; 2007 Apr; 1770(4):556-64. PubMed ID: 17292554
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor inhibits nuclear factor κB activation by interacting with IκB kinase β protein.
Chen Y; Zhang J; Ge X; Du J; Deb DK; Li YC
J Biol Chem; 2013 Jul; 288(27):19450-8. PubMed ID: 23671281
[TBL] [Abstract][Full Text] [Related]
20. 1,25-dihydroxyvitamin D3 inhibits nuclear factor kappa B activation by stabilizing inhibitor IκBα via mRNA stability and reduced phosphorylation in passively sensitized human airway smooth muscle cells.
Song Y; Hong J; Liu D; Lin Q; Lai G
Scand J Immunol; 2013 Feb; 77(2):109-16. PubMed ID: 23126502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
